PETC/CT with 18F-Choline localizes hyperfunctioning parathyroid adenomas equally well in normocalcemic hyperparathyroidism as in overt hyperparathyroidism
Jazyk angličtina Země Itálie Médium print-electronic
Typ dokumentu časopisecké články
PubMed
30094743
DOI
10.1007/s40618-018-0931-z
PII: 10.1007/s40618-018-0931-z
Knihovny.cz E-zdroje
- Klíčová slova
- Normocalcemic hyperparathyroidism, PETC/CT with 18F-Choline, Primary hyperparathyroidism,
- MeSH
- cholin analogy a deriváty MeSH
- dospělí MeSH
- hyperkalcemie diagnostické zobrazování patologie chirurgie MeSH
- hyperparatyreóza diagnostické zobrazování patologie chirurgie MeSH
- kohortové studie MeSH
- lidé středního věku MeSH
- lidé MeSH
- nádory příštítného tělíska diagnostické zobrazování patologie chirurgie MeSH
- následné studie MeSH
- PET/CT metody MeSH
- prognóza MeSH
- radiofarmaka MeSH
- radioisotopová scintigrafie metody MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ultrasonografie metody MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- cholin MeSH
- fluorocholine MeSH Prohlížeč
- radiofarmaka MeSH
PURPOSE: Identification of pathologic parathyroid glands in primary hyperparathyroidism, traditionally based on neck ultrasound (US) and/or 99mTc-Sestamibi scintigraphy, can be challenging. PET/CT with 18F-Fluorocholine (18F-FCH) might improve the detection of pathologic parathyroid glands. We aimed at comparing the diagnostic performance of 18F-FCH-PET/CT with that of dual-phase dual-isotope parathyroid scintigraphy and neck US. METHODS: Thirty-four consecutive patients with primary hyperparathyroidism were prospectively enrolled, 7 had normocalcemic hyperparathyroidism, and 27 had classic hypercalcemic hyperparathyroidism. All patients underwent high-resolution neck US, dual-phase dual-isotope 99mTc-Pertechnetate/99mTc-Sestamibi scintigraphy, and 18F-FCH-PET/CT. RESULTS: In the whole patients' group, the detection rates of the abnormal parathyroid gland were 68% for neck US, 71% for 18F-FCH-PET/CT, and only 15% for 99mTc-Sestamibi scintigraphy. The corresponding figures in normocalcemic and hypercalcemic hyperparathyroidism were 57 and 70% for neck US, 70 and 71% for 18F-FCH-PET/CT, and 0 and 18% for 99mTc-Sestamibi scintigraphy, respectively. In the 17 patients in whom the abnormal parathyroid gland was identified, either at surgery or at fine needle aspiration cytology/biochemistry, the correct detection rate was 82% for neck US, 89% for 18F-FCH-PET/CT, and only 17% for 99mTc-Sestamibi scintigraphy. CONCLUSIONS: 18F-FCH-PET/CT can be considered a first-line imaging technique for the identification of pathologic parathyroid glands in patients with normocalcemic and hypercalcemic hyperparathyroidism, even when the parathyroid volume is small.
Faculty of Medicine and Dentistry Palacký University Olomouc Czech Republic
Inter Universitary Research Center for Sustainable Development Naples Italy
Nuclear Medicine Department Iason Graz Austria
Nuclear Medicine Department Policlinico S Orsola Malpighi University of Bologna Bologna Italy
Nuclear Medicine Research Department Iason Graz Austria
Regional Center of Nuclear Medicine University of Pisa Pisa Italy
Zobrazit více v PubMed
J Nucl Med. 2003 Sep;44(9):1443-58 PubMed
Otolaryngol Head Neck Surg. 2005 Mar;132(3):359-72 PubMed
Laryngoscope. 2006 Apr;116(4):580-5 PubMed
J Clin Endocrinol Metab. 2007 Aug;92(8):3001-5 PubMed
J Clin Endocrinol Metab. 2009 Feb;94(2):335-9 PubMed
Arq Bras Endocrinol Metabol. 2010 Mar;54(2):106-9 PubMed
World J Surg. 2012 Apr;36(4):761-6 PubMed
J Clin Endocrinol Metab. 2013 Jul;98(7):2734-41 PubMed
Eur J Nucl Med Mol Imaging. 2014 Nov;41(11):2083-9 PubMed
J Clin Endocrinol Metab. 2014 Dec;99(12):4531-6 PubMed
J Clin Endocrinol Metab. 2015 Jun;100(6):2420-4 PubMed
Eur J Nucl Med Mol Imaging. 2015 Nov;42(12):1941-2 PubMed
Endocr Pract. 2016 Mar;22(3):294-301 PubMed
Langenbecks Arch Surg. 2016 Nov;401(7):925-935 PubMed
Nucl Med Mol Imaging. 2016 Jun;50(2):180-2 PubMed
Can Assoc Radiol J. 2017 Feb;68(1):47-55 PubMed
Clin Nucl Med. 2017 Dec;42(12):e491-e497 PubMed
J Nucl Med. 1998 May;39(5):822-5 PubMed